Director - Neuroscience at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

PhD in Biology, Biochemistry, Neuroscience, Neurophysiology, or related scientific discipline with 10+ years industry or academic experience beyond any postdoctoral positions
Alternatively, a Masters degree in Neuroscience, Neurophysiology, or related scientific discipline with 20+ years industry or academic work experience leading a laboratory and leading discovery projects through preclinical development
Solid background in Neuroscience with deep understanding of neuronal plasticity, emphasis on psychiatric and neurodevelopmental disorders
Demonstrated ability to lead a laboratory in industry and/or biotech providing critical and robust decisional data
Clear understanding of pharmacology principles and measures of target engagement ex vivo or in vivo to drive human dose projections (preferred)
Demonstrated ability to lead a cross-functional team and translate preclinical biomarkers to clinical development (preferred)
Experience preparing documents for regulatory filings (preferred)
Excellent communication and presentation skills
Ability to work both independently and in cross-functional teams, influencing beyond direct reports
Demonstrated expertise in Neuroscience research as evidenced by peer-reviewed publication record
20-30% travel
On-site position at Lilly Corporate Center in Indianapolis, Indiana and/or Lilly Seaport Innovation Center in Boston, Massachusetts

Responsibilities

Supervise a group of dedicated laboratory neuroscientists
Lead cross-functional teams in preclinical drug development phase
Present data and conclusions to leadership and decision makers in a clear, balanced, and compelling manner
Identify, develop, and implement innovative approaches to add functional capabilities and gain new insights into psychiatric and neurological disease biology, target engagement, and pharmacodynamics
Develop preclinical in vivo biomarker assays, such as EEG, for translational early clinical phase development (desirable)
Work collaboratively across multiple geographies of Lilly’s research sites

Skills

Neuroscience

Neuronal Plasticity

EEG

In Vivo Assays

Biomarker Assays

Preclinical Drug Development

Laboratory Leadership

Cross-Functional Teams

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free